Related Experiment Video
Updated: Oct 17, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Endocytic protein intersectin1-S shuttles into nucleus to suppress the DNA replication in breast cancer
Huikun Zhang1,2,3,4, Zhifang Guo1,2,3,4, Xiaoli Liu1,2,3,4
1Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Abstract:
Breast cancer is the most common type of cancer worldwide. However, the well-known molecular biomarkers are not enough to meet the needs of precision medicine. In search for novel targets in this regard, we reported ITSN1 (intersectin1) as one of the candidates through mRNA microarray analysis. In the present study, we reported that endocytic protein ITSN1-S exists not only in the cytoplasm but also in nuclei of breast cancer cells. ITSN1-S' functional nuclear localization signal is within its residues 306-312. Its nuclear export signal (NES) resides within its SH3 domains. We also found, the interaction between the CC domain of nuclear ITSN1-S and the NT domain of nuclear DNA helicase II (NDH II) directly suppressed the DNA replication and nascent DNA synthesis by inhibiting the R-loops resolution in breast cancer cells. Furthermore, the interaction between the EH domains of cytoplasmic ITSN1-S and PI3KC2α inhibit cell migration and invasion by inactivating the PI3KC2α-AKT pathway. Our results were confirmed in both ITSN1 gene knockout cells and in vivo assays. Finally, our clinical data showed a potential application of the combined consideration of the cytoplasmic and nuclear ITSN1-S as an independent prognosis factor. In conclusion, our study revealed ITSN1-S' novel positioning in the nuclei of breast cancer cells, its function in suppressing DNA replication, and its potential application in improved breast cancer prognosis.
Insights
Intersectin1-S (ITSN1-S) is found in breast cancer cell nuclei, suppressing DNA replication and R-loop resolution. This discovery offers a novel prognostic factor for breast cancer precision medicine.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast cancer requires novel biomarkers for precision medicine.
- Existing molecular biomarkers are insufficient for personalized treatment strategies.
- Intersectin1 (ITSN1) emerged as a candidate target from mRNA microarray analysis.
Purpose of the Study:
- To investigate the localization and function of intersectin1-S (ITSN1-S) in breast cancer cells.
- To identify novel molecular mechanisms and potential prognostic factors in breast cancer.
- To explore the role of ITSN1-S in DNA replication, cell migration, and invasion.
Main Methods:
- Investigated ITSN1-S localization in breast cancer cell nuclei and cytoplasm.
- Identified nuclear localization and export signals within ITSN1-S.
- Utilized ITSN1 gene knockout cells and in vivo assays for validation.
- Analyzed interactions between ITSN1-S domains and other proteins (NDH II, PI3KC2α).
- Assessed impact on DNA replication, R-loop resolution, cell migration, and invasion.
Main Results:
- ITSN1-S is present in both the cytoplasm and nucleus of breast cancer cells.
- Nuclear ITSN1-S interacts with nuclear DNA helicase II (NDH II), suppressing DNA replication and R-loop resolution.
- Cytoplasmic ITSN1-S interacts with PI3KC2α, inhibiting cell migration and invasion via the PI3KC2α-AKT pathway.
- Results were validated in ITSN1 knockout cells and in vivo models.
- Clinical data suggests combined cytoplasmic and nuclear ITSN1-S is a potential independent prognostic factor.
Conclusions:
- ITSN1-S exhibits novel nuclear localization in breast cancer cells.
- ITSN1-S plays a dual role in suppressing DNA replication and cell invasion.
- ITSN1-S represents a promising novel prognostic biomarker for breast cancer.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Abnormal Proliferation

